These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6275413)

  • 1. The development of gamma-emitting hormone analogs as imaging agents for receptor-positive tumors.
    Katzenellenbogen JA
    Prog Clin Biol Res; 1981; 75B():313-27. PubMed ID: 6275413
    [No Abstract]   [Full Text] [Related]  

  • 2. 16 alpha-[77Br]bromoestradiol: dosimetry and preliminary clinical studies.
    McElvany KD; Katzenellenbogen JA; Shafer KE; Siegel BA; Senderoff SG; Welch MJ
    J Nucl Med; 1982 May; 23(5):425-30. PubMed ID: 7077397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin and estrogen receptors in breast cancer.
    McGuire WL; Chamness GC; Horwitz KB; Zava DT
    Pathobiol Annu; 1977; 7():191-211. PubMed ID: 201904
    [No Abstract]   [Full Text] [Related]  

  • 4. Receptor-binding radiopharmaceuticals for imaging breast tumors: estrogen-receptor interactions and selectivity of tissue uptake of halogenated estrogen analogs.
    Katzenellenbogen JA; Carlson KE; Heiman DF; Goswami R
    J Nucl Med; 1980 Jun; 21(6):550-8. PubMed ID: 6247466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundamental considerations in the design of fluorine-18 labeled progestins and androgens as imaging agents for receptor-positive tumors of the breast and prostate.
    Brandes SJ; Katzenellenbogen JA
    Int J Rad Appl Instrum B; 1988; 15(1):53-67. PubMed ID: 3280523
    [No Abstract]   [Full Text] [Related]  

  • 6. The search for a gamma-emitting estrogenic ligand.
    Krohn KA
    J Nucl Med; 1980 Jun; 21(6):593-5. PubMed ID: 6247467
    [No Abstract]   [Full Text] [Related]  

  • 7. [Steroid hormone receptors in breast cancer (a review of the literature)].
    Korolev VI; Dziubko NIa; Tarutinov VI
    Vrach Delo; 1988 Nov; (11):86-91. PubMed ID: 2853492
    [No Abstract]   [Full Text] [Related]  

  • 8. [Round table discussion: "Nuclear medicine in oncology"].
    Nuklearmedizin; 1980; 19(2):49-53. PubMed ID: 7413437
    [No Abstract]   [Full Text] [Related]  

  • 9. Polymorphism of estrogen receptors in human breast cancer.
    Wittliff JL; Feldhoff PW; Fuchs A; Wiehle RD
    Prog Clin Biol Res; 1981; 74():375-96. PubMed ID: 6275406
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormone dependence and the basis of hormone therapy in breast cancer].
    Martin PM
    J Gynecol Obstet Biol Reprod (Paris); 1978 Mar; 7(2):183-99. PubMed ID: 209076
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug interaction with estrogen receptors for the control of breast neoplasia (review).
    Leclercq G; Heuson JC
    Anticancer Res; 1981; 1(4):217-28. PubMed ID: 7049050
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential use of radiolabelled porphyrins for tumor scanning.
    Thaller RA; Lyster DM; Dolphin D
    Adv Exp Med Biol; 1983; 160():265-78. PubMed ID: 6220576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane-initiated steroid signaling action of estrogen and breast cancer.
    Song RX
    Semin Reprod Med; 2007 May; 25(3):187-97. PubMed ID: 17447208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic estrogens in hormone receptive tumors.
    Raus J; Martens H; Leclercq G
    J Toxicol Environ Health; 1981 Jan; 7(1):159-65. PubMed ID: 7265294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
    Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
    Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estrogen dependence of mammary gland tumors: the mechanisms of the disorder and the evaluation criteria].
    Merkulova TI; Morozova TM; Sakganik RI
    Vopr Onkol; 1980; 26(10):67-75. PubMed ID: 7434681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioiodinated DNA as potential tumor-imaging agent.
    Ithakissios DS; Hapke B
    J Nucl Med; 1979 Jul; 20(7):785-8. PubMed ID: 541716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
    Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS
    Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and prolactin receptor concentrations in rat mammary tumors and response to endocrine ablation.
    DeSombre ER; Kledzik G; Marshall S; Meites J
    Cancer Res; 1976 Feb; 36(2 Pt 1):354-8. PubMed ID: 177195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies with 17 beta(16 alpha-[125i]iodo)-estradiol, an estrogen receptor-binding radiopharmaceutical, in rats bearing mammary tumors.
    Gatley SJ; Shaughnessy WJ; Inhorn L; Leiberman LM
    J Nucl Med; 1981 May; 22(5):459-64. PubMed ID: 7218023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.